NEW YORK (AP) — Shares of ProQR Therapeutics are surging after the Dutch drugmaker's expanded IPO priced at the top of its expected range.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Thu, 09/18/2014 - 9:39am
NEW YORK (AP) — Shares of ProQR Therapeutics are surging after the Dutch drugmaker's expanded IPO priced at the top of its expected range.